Only 30.57% of Sanofi Consumer Open Offer Shares Tendered So Far

K N Mishra

    07/May/2025

What’s covered under the Article

  • Only 18.3 lakh equity shares out of the total 59.88 lakh offer size were tendered by May 6, comprising just 30.57% of the Open Offer.

  • The Open Offer is by Opal Bidco SAS and Clayton, Dubilier & Rice Fund XII, L.P., as per SEBI SAST Regulations.

  • Tendered shares are still subject to verification, and valid acceptance will follow the LoF dated April 12, 2025.

On May 6, 2025, an important update was provided concerning the open offer for the acquisition of up to 59,87,962 equity shares of Sanofi Consumer Healthcare India Limited. The offer, being made by Opal Bidco SAS together with Clayton, Dubilier & Rice Fund XII, L.P. (acting in concert), aims to acquire 26% of the voting share capital of the company. This offer is in accordance with the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, commonly referred to as the SEBI (SAST) Regulations.

The current status of the open offer indicates that a total of 18,30,349 equity shares have been tendered to date. This amounts to 30.57% of the offer size, as per the Open Offer Escrow Demat Account statement. Specifically, 2,95,708 equity shares were tendered on May 6, 2025, constituting 4.94% of the total offer size. These shares have been tendered in the Open Offer Escrow Demat Account, which is held with Ventura Securities Limited, under the depository participant identification number IN303116 and client ID 15236516.

It is important to note that these tendered shares are still subject to validation and verification. The Public Shareholders who have tendered their shares must provide a complete set of documents as required by the regulations. The final number of shares that will be accepted by the acquirer will depend on the validation process. As of now, the shares tendered do not represent the final number of accepted shares. The acceptance of the shares will occur in accordance with the letter of offer dated April 12, 2025 (LoF) and the provisions outlined in the SEBI (SAST) Regulations.

This open offer is an important step in Opal Bidco SAS's strategy to acquire a significant share in Sanofi Consumer Healthcare India Limited. The information provided in the statement will be made available on the relevant websites for public reference, and the details will continue to evolve as the offer progresses.

We also request that the BSE Limited disseminate this information via their website for wider access and transparency. For further updates on the open offer and its status, stakeholders are encouraged to refer to the offer documents and announcements made available by the acquirer and the involved parties.

This update is critical for public shareholders, as the process of tendering shares and the potential acquisition could affect shareholder positions and valuations, so following the regulations and ensuring proper documentation will be vital to the successful completion of the offer.

The letter concludes with a request for public dissemination on the official websites of the BSE and relevant parties involved.

The Upcoming IPOs in this week and coming weeks are Virtual Galaxy InfotechWagons Learning.


The Current active IPO are Srigee DLMManoj Jewellers.


Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.


Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.

Related News

Disclaimer

The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.

Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.

We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.

You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.

By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.

onlyfans leakedonlyfan leaksonlyfans leaked videos